When the HMME+PFP/PLGA-SA was added, the high-affinity biotin-avidin system could rapidly and stably combine with the biotinylated VEGFR2 antibody, increasing the number of nanoparticles in the tumor tissue. The gene discussed is KDR; the disease is neoplasm.